We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Melanomas Are "Born to Run”

By Biotechdaily staff writers
Posted on 13 Oct 2005
Cancer researchers have learned why melanomas are so aggressively malignant while other types of cancer may require years of development before being able to metastasize.

Investigators at the Massachusetts Institute of Technology (Cambridge, USA) found that a gene called SLUG (named after the embryo shape that the mutated gene causes in fruit flies), which is turned off in normal adult tissue, is activated in melanomas. More...
SLUG is a leftover from the neural crest developmental stage when primal melanocytes are formed. Cells with active SLUG are readily able to spread throughout the body.

When melanoma cells were genetically engineered to lack SLUG activity, they were unable to metastasize after being transplanted into susceptible mice. Detailed findings were published in September 4, 2005, online edition of Nature Genetics.
"Other cancers need to learn how to spread, but not melanoma,” said senior author Dr. Robert Weinberg, professor of biology at MIT. "Now, for the first time, we understand the genetic mechanism responsible for this.”



Related Links:
Massachusetts Institute of Technology

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.